Why Stool Testing Has Exploded in Popularity

Comprehensive stool testing has become one of the most requested functional medicine investigations, and for good reason. A single stool sample can reveal information about your gut microbiome composition, digestive enzyme function, immune activation, inflammation levels, intestinal permeability, and the presence of pathogens, parasites, or yeast overgrowth. However, the multi-page reports generated by these tests are dense with technical terminology and reference ranges that can be confusing without guidance.

This guide explains the most common markers found on comprehensive stool panels, what they mean clinically, and when values outside the reference range are truly significant.

Digestive Function Markers

Pancreatic Elastase

This enzyme is produced exclusively by the pancreas and is resistant to degradation by other enzymes. It serves as a reliable marker of exocrine pancreatic function (your pancreas's ability to produce digestive enzymes).

  • Normal: above 200 mcg/g — adequate pancreatic enzyme production
  • Moderate insufficiency: 100-200 mcg/g — may benefit from supplemental enzymes with meals
  • Severe insufficiency: below 100 mcg/g — significant enzyme deficiency requiring prescription pancreatic enzyme replacement and further investigation

Fecal Fat (Steatocrit or Total Fecal Fat)

Elevated fecal fat indicates fat malabsorption, which can result from pancreatic insufficiency, bile acid deficiency, mucosal damage (as in celiac disease), or SIBO. This marker should be interpreted alongside pancreatic elastase to determine the likely cause of malabsorption.

Inflammatory and Immune Markers

Calprotectin

As discussed in detail in our dedicated article, calprotectin reflects neutrophilic inflammation in the gut wall. Below 50 mcg/g is normal. Above 200 mcg/g warrants further investigation for IBD or other causes of intestinal inflammation.

Secretory IgA (sIgA)

sIgA is the primary immunoglobulin of the mucosal immune system. It acts as the first line of immune defence in the gut, neutralising pathogens and preventing bacterial adhesion to the gut wall.

  • Elevated sIgA — suggests active immune response to a gut pathogen, parasite, food antigen, or dysbiosis. The immune system is actively fighting something
  • Low sIgA — suggests mucosal immune suppression, which can occur from chronic stress (cortisol suppresses sIgA), chronic infections that have exhausted the immune response, or IgA deficiency (the most common primary immunodeficiency)
Chronically low sIgA is clinically significant because it means the gut's first-line immune defence is weakened, increasing susceptibility to gut infections, dysbiosis, and food-borne pathogens. Chronic stress is one of the most common causes of low sIgA.

Eosinophil Protein X (EPX)

EPX is a marker of eosinophilic inflammation, which is associated with food allergies, parasitic infections, and eosinophilic gastrointestinal disorders. Elevated EPX in the context of negative parasite testing may suggest food-mediated eosinophilic inflammation.

Microbiome Markers

Bacterial Diversity and Composition

Most comprehensive panels report the relative abundance of major bacterial phyla and genera. Key things to look for:

  • Firmicutes to Bacteroidetes ratio — a very rough indicator of metabolic status, though oversimplified. Extreme imbalances warrant attention
  • Butyrate-producing bacteria (Faecalibacterium, Roseburia, Eubacterium) — these should be well-represented; low levels suggest inadequate fibre intake or dysbiosis
  • Overall diversity — higher diversity is generally associated with better health outcomes

Commensal Bacteria Balance

Reports typically flag bacteria that are below or above expected ranges. Do not panic about individual markers. What matters most is the overall pattern: are multiple beneficial species depleted? Are multiple opportunistic organisms elevated? The pattern tells a story that individual markers cannot.

Opportunistic and Pathogenic Organisms

Most panels report the presence and quantity of potentially pathogenic bacteria (C. diff toxins, Salmonella, Campylobacter), parasites (Giardia, Cryptosporidium, Blastocystis), and yeast (Candida species). The clinical significance depends on the quantity detected and whether symptoms correlate.

Metabolic Markers

Short-Chain Fatty Acids (SCFAs)

Some panels measure butyrate, propionate, and acetate levels directly. Low butyrate is clinically significant because butyrate is the primary fuel for colonocytes and plays critical roles in barrier integrity and immune regulation. Low butyrate usually indicates insufficient dietary fibre diversity.

Beta-Glucuronidase

This enzyme, produced by certain gut bacteria, deconjugates oestrogens and toxins that the liver has prepared for excretion. Elevated beta-glucuronidase means your gut is reactivating and recirculating compounds your liver was trying to eliminate. This has implications for hormonal balance and detoxification capacity.

How to Use Your Results

Do not attempt to interpret a comprehensive stool test in isolation. Always review results with a practitioner experienced in functional gut health assessment. The most common mistake is treating individual markers in isolation rather than understanding the overall pattern. GutIQ complements stool testing by providing the symptom context that helps interpret whether abnormal markers are clinically significant or incidental findings.